Arteris, Inc. (AIP)
:AIP
US Market
Advertisement

Arteris (AIP) AI Stock Analysis

Compare
352 Followers

Top Page

AIP

Arteris

(NASDAQ:AIP)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 4o)
Rating:52Neutral
Price Target:
$15.50
▼(-0.06% Downside)
Arteris' overall stock score is primarily impacted by its financial performance challenges, including negative equity and cash flow issues. While technical analysis shows a bullish trend, the valuation remains unattractive due to a negative P/E ratio. The earnings call highlights some positive developments, but ongoing financial challenges weigh heavily on the score.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand for Arteris' products, suggesting a solid market position and potential for continued expansion.
Product Adoption
Growing adoption in AI and automotive sectors highlights Arteris' competitive edge and ability to meet evolving industry needs, supporting long-term growth.
Cash Position
A strong cash position and no debt provide financial flexibility, enabling investment in growth opportunities and resilience against economic fluctuations.
Negative Factors
Operating Loss
Continued operating losses indicate challenges in achieving profitability, which could impact long-term financial health and investment capacity.
Delayed Royalty Revenue
Delayed royalty revenue realization affects cash flow predictability, posing challenges for financial planning and operational stability.
Negative Equity
Negative equity suggests financial instability, raising concerns about solvency and the company's ability to sustain operations without restructuring.

Arteris (AIP) vs. SPDR S&P 500 ETF (SPY)

Arteris Business Overview & Revenue Model

Company DescriptionArteris, Inc. provides semiconductor interconnect intellectual property (IP) and IP deployment solutions in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in System-on-Chip (Soc) designs and Network-on-Chip (NoC) interconnect IP. Its products include FlexNoC, a silicon-proven interconnect IP product; FlexNoC Resilience Package, which provides on-chip data protection; Ncore, a silicon-proven and cache coherent interconnect IP product that provides scalable, configurable, and area efficient characteristics; CodaCache, a last-level cache semiconductor IP product; and Physical interconnect aware NoC optimizer, a software tool that estimates physical layout effects during the architecture and logic development stages of an SoC interconnect design; The company also offers FlexWay for IP subsystem interconnect; FlexPSI for All-digital inter chip link; and FlexNoC Physical for linking physical placement and routing tools. In addition, it provides IP deployment software solutions, including specification, design, documentation, artificial intelligence (AI) package, design data intelligence, and harmony trace. The company serves customers in the automotive, AI/machine learning, 5G and wireless communications, data centers, consumer electronics, and other markets. Arteris, Inc. was founded in 2003 and is headquartered in Campbell, California.
How the Company Makes MoneyArteris generates revenue primarily through the licensing of its intellectual property and software solutions to semiconductor companies and system designers. This includes upfront license fees and ongoing royalties based on the usage of its NoC technology and other design tools. Additionally, the company may offer professional services, including training and technical support, which contribute to its revenue. Significant partnerships with major semiconductor firms and participation in industry alliances enhance its market presence and lead to collaborative projects that further drive revenue growth.

Arteris Earnings Call Summary

Earnings Call Date:Nov 04, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 04, 2026
Earnings Call Sentiment Neutral
The earnings call reflects a strong performance with record contract values, increased product adoption in AI and automotive sectors, and positive cash flow. However, challenges remain with operating losses and delayed royalty revenue realization. The sentiment is balanced with significant progress and ongoing financial challenges.
Q3-2025 Updates
Positive Updates
Record Annual Contract Value and Royalties
Arteris achieved a record annual contract value plus royalties of $74.9 million, reflecting a 24% year-over-year growth.
Increased Product Adoption in AI and Automotive
AI applications accounted for over half of licensing dollars, and significant adoption was seen in automotive, with new customers deploying FlexGen for next-generation EVs and high-end automotive semiconductor designs.
Strong Financial Performance
Total revenue for the third quarter was $17.4 million, up 5% sequentially and 18% year-over-year, exceeding guidance. Remaining performance obligations increased by 34% year-over-year.
Positive Cash Flow and No Debt
Arteris ended the quarter with $56.2 million in cash, cash equivalents, and investments with no financial debt. Free cash flow was positive at $2.5 million.
Recognition and Awards
Arteris was recognized as the most innovative technology company of the year by the 22nd Annual International Business Awards.
Negative Updates
Operating Loss
GAAP operating loss for the third quarter was $8.7 million compared to a loss of $7.9 million in the prior year period.
Non-GAAP Net Loss
Non-GAAP net loss for the quarter was $3.8 million or diluted net loss per share of $0.09.
Delayed Royalty Revenue
It is noted that there is a significant lag, often 3-6 years, between design starts and mass production, affecting the timing of royalty revenue realization.
Company Guidance
During Arteris' third quarter 2025 earnings call, the company provided guidance for the fourth quarter and the full year of 2025. For Q4 2025, Arteris anticipates annual contract value (ACV) plus royalties to be between $74 million and $78 million, with revenue projected to range from $18.4 million to $18.8 million. The company expects a non-GAAP operating loss of $2.3 million to $3.3 million and non-GAAP free cash flow of $0.2 million to $3.2 million for the quarter. For the full year 2025, Arteris has raised its guidance, forecasting ACV plus royalties to exit the year between $74 million and $78 million, and revenue to reach $68.8 million to $69.2 million. The company also projects a non-GAAP operating loss of $12.5 million to $13.5 million and non-GAAP free cash flow of $2.5 million to $5.5 million. This guidance reflects Arteris' strong deal execution and growing customer interest in outsourcing system IP products, which they believe will enhance their growth in license and royalty revenue, ACV plus royalties, and positive free cash flow.

Arteris Financial Statement Overview

Summary
Arteris faces significant financial challenges, with consistent revenue growth overshadowed by persistent profitability issues and negative equity. The high gross profit margin suggests operational efficiency, but the inability to achieve net profitability and positive cash flow indicates underlying financial instability. The company needs to address its leverage and cash flow issues to improve its financial health.
Income Statement
45
Neutral
Arteris shows a consistent revenue growth trend, with a 4.26% increase in TTM. However, the company struggles with profitability, as evidenced by negative net profit margins and EBIT margins over the periods. The gross profit margin remains high, indicating efficient production, but the inability to translate this into net profits is concerning.
Balance Sheet
30
Negative
The balance sheet reveals a negative stockholders' equity in the TTM, indicating financial instability. The debt-to-equity ratio is negative, suggesting high leverage and potential risk. Although there was a positive return on equity in the TTM, it is due to negative equity, which is not sustainable.
Cash Flow
35
Negative
Cash flow analysis shows negative free cash flow growth in the TTM, indicating cash generation issues. The operating cash flow to net income ratio is low, reflecting challenges in converting income into cash. The free cash flow to net income ratio is negative, further highlighting cash flow concerns.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue65.93M57.72M53.67M50.38M37.86M31.81M
Gross Profit59.32M51.76M48.59M46.10M34.13M30.32M
EBITDA-25.87M-24.83M-28.52M-25.33M-20.27M-1.25M
Net Income-34.45M-33.64M-36.87M-27.39M-23.38M-3.26M
Balance Sheet
Total Assets107.74M106.14M102.80M115.52M120.44M42.74M
Cash, Cash Equivalents and Short-Term Investments39.08M43.84M41.17M68.15M85.83M11.74M
Total Debt6.86M5.99M7.75M3.62M3.91M4.77M
Total Liabilities119.19M107.32M87.70M77.98M67.54M49.03M
Stockholders Equity-11.45M-1.19M15.10M37.53M52.90M-6.30M
Cash Flow
Free Cash Flow-372.00K-1.04M-17.23M-7.82M-1.62M1.51M
Operating Cash Flow932.00K-720.00K-15.73M-6.77M-814.00K2.16M
Investing Cash Flow-2.98M970.00K-4.69M-37.48M-1.36M-5.15M
Financing Cash Flow1.69M-262.00K-2.92M-4.15M76.25M790.00K

Arteris Technical Analysis

Technical Analysis Sentiment
Positive
Last Price15.51
Price Trends
50DMA
11.83
Positive
100DMA
10.69
Positive
200DMA
9.29
Positive
Market Momentum
MACD
0.79
Negative
RSI
61.82
Neutral
STOCH
74.40
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AIP, the sentiment is Positive. The current price of 15.51 is above the 20-day moving average (MA) of 13.93, above the 50-day MA of 11.83, and above the 200-day MA of 9.29, indicating a bullish trend. The MACD of 0.79 indicates Negative momentum. The RSI at 61.82 is Neutral, neither overbought nor oversold. The STOCH value of 74.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AIP.

Arteris Risk Analysis

Arteris disclosed 66 risk factors in its most recent earnings report. Arteris reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Arteris Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$314.27M22.7422.20%6.13%-9.48%-14.28%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
53
Neutral
$1.14B-45.62%-44.30%16.42%
52
Neutral
$652.64M20.45%12.28%
51
Neutral
$624.76M-4.22%5.55%-239.94%
51
Neutral
$169.15M-24.56%8.70%-13.95%
39
Underperform
$354.88M-3299.52%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AIP
Arteris
15.51
7.23
87.32%
CEVA
Ceva
26.08
-1.61
-5.81%
NVEC
NVE
65.29
-7.41
-10.19%
VLN
Valens
1.80
-0.02
-1.10%
BZAI
Blaize Holdings
2.86
-8.52
-74.87%
LAES
SEALSQ Corp
5.53
5.14
1317.95%

Arteris Corporate Events

Arteris, Inc. Earnings Call Highlights Growth and Challenges
Nov 6, 2025

Arteris, Inc. recently held its earnings call, revealing a balanced sentiment of strong performance and ongoing financial challenges. The company celebrated record contract values and increased product adoption, particularly in the AI and automotive sectors, while also acknowledging hurdles such as operating losses and delayed royalty revenue realization.

Arteris, Inc. Reports Strong Q3 Growth Amid Losses
Nov 5, 2025

Arteris, Inc. is a prominent player in the semiconductor industry, specializing in system IP that enhances the development of high-performance, energy-efficient silicon chips. The company is known for its network-on-chip (NoC) interconnect IP and SoC integration automation software, catering to leading semiconductor and technology firms globally.

Arteris, Inc. Navigates Competitive Pressures and Financial Uncertainties Amid Global Expansion
Aug 7, 2025

Arteris, Inc. faces a multitude of business risks that could significantly impact its financial health and operational success. The company is challenged by intense competition from larger entities and third-party providers, which may develop their own IP solutions, potentially reducing demand for Arteris’s offerings. Additionally, the company’s reliance on the acceptance of its semiconductor IP solutions by various market sectors, coupled with its history of net losses, underscores the uncertainty of achieving sustained profitability. Furthermore, Arteris’s dependence on international operations exposes it to regulatory and political risks, while its ongoing need for substantial R&D investment could strain financial resources, especially if anticipated revenues do not materialize.

Arteris, Inc. Earnings Call: Growth Amidst Challenges
Aug 7, 2025

Arteris, Inc. recently held its earnings call, revealing a generally positive sentiment with strong revenue growth and strategic customer wins, such as a significant agreement with AMD. However, the company also faced challenges, including increased operating expenses and negative free cash flow, influenced by foreign exchange impacts.

Arteris Reports Record Contract Value and Revenue Growth
Aug 6, 2025

Arteris, Inc. is a prominent provider of semiconductor system IP, specializing in accelerating the creation of system-on-chip (SoC) designs for high-performance and power-efficient silicon, serving leading semiconductor and technology companies globally. In its latest earnings report, Arteris announced a record Annual Contract Value plus royalties of $69.1 million for the second quarter of 2025, alongside a 13% year-over-year increase in revenue to $16.5 million. The company also reported a net loss of $9.1 million, or $0.22 per share, reflecting ongoing investments in research and development and sales and marketing efforts. Key highlights from the quarter include strategic partnerships and product innovations, such as AMD licensing Arteris’ FlexGen smart network-on-chip IP and the introduction of Magillem Packaging software to streamline chiplet and SoC assembly. Looking ahead, Arteris remains optimistic about its growth prospects, supported by a robust product portfolio and strong industry partnerships, as it continues to target high-growth markets like AI, autonomous driving, and advanced communications.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 06, 2025